Compounds > moxifloxacin
Page last updated: 2024-09-04

moxifloxacin and Brucellosis

moxifloxacin has been researched along with Brucellosis in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Dai, Q; Ding, J; Xie, S; Xu, Z; Zhang, Y; Zheng, R; Zhou, Y; Zuo, W1
Cheng, J; Huo, N; Li, J; Li, Y; Lin, X; Tian, G; Wan, H; Wang, G; Wang, Y; Yang, X; Zhao, H1
Cetinkaya, B; Demirdag, K; Denk, A; Kalkan, A; Kilic, SS; Ozden, M1
Atkins, HS; Brew, SD; Brooks, TJ; Laws, TR; MacMillan, AP; Simpson, AJ; Spencer, S; Thirlwall, RE1
Cardeñosa, O; Contreras-Rodríguez, A; Gutiérrez-Rubio, AT; Hernández-Oliva, GM; López-Merino, A; Migranas-Ortiz, R; Orrantia-Gradín, R1
Cakir, N; Kuruuzum, Z; Sezak, N; Yuce, A1

Reviews

1 review(s) available for moxifloxacin and Brucellosis

ArticleYear
Brucellar reproductive system injury: A retrospective study of 22 cases and review of the literature.
    The Journal of international medical research, 2020, Volume: 48, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Brucella; Brucellosis; China; Doxycycline; Drug Therapy, Combination; Female; Genitalia; Humans; Levofloxacin; Male; Middle Aged; Moxifloxacin; Retrospective Studies; Rifampin

2020

Other Studies

5 other study(ies) available for moxifloxacin and Brucellosis

ArticleYear
Renal abscess caused by Brucella.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2014, Volume: 28

    Topics: Abscess; Anti-Bacterial Agents; Brucella melitensis; Brucellosis; Drug Therapy, Combination; Fluoroquinolones; Humans; Kidney Diseases; Male; Middle Aged; Minocycline; Moxifloxacin; Rifampin

2014
In vitro activity of Brucella melitensis isolates to various antimicrobials in Turkey.
    Infectious diseases (London, England), 2015, Volume: 47, Issue:6

    Topics: Anti-Bacterial Agents; Brucella melitensis; Brucellosis; Doxycycline; Fluoroquinolones; Humans; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Moxifloxacin; Polymerase Chain Reaction; Quinolones; Serotyping; Turkey

2015
Efficacy of moxifloxacin or gatifloxacin as prophylaxis against experimental murine Brucella melitensis infection.
    International journal of antimicrobial agents, 2009, Volume: 34, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Brucella melitensis; Brucellosis; Colony Count, Microbial; Doxycycline; Female; Fluoroquinolones; Gatifloxacin; Mice; Mice, Inbred BALB C; Moxifloxacin; Quinolines; Spleen; Treatment Outcome

2009
Susceptibility of Mexican brucella isolates to moxifloxacin, ciprofloxacin and other antimicrobials used in the treatment of human brucellosis.
    Scandinavian journal of infectious diseases, 2004, Volume: 36, Issue:9

    Topics: Anti-Bacterial Agents; Aza Compounds; Brucella; Brucellosis; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Mexico; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Sensitivity and Specificity

2004
Comparison of rifampicin and moxifloxacin efficacy in an experimental model of animal brucellosis.
    Journal of chemotherapy (Florence, Italy), 2008, Volume: 20, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Brucellosis; Disease Models, Animal; Fluoroquinolones; Moxifloxacin; Quinolines; Rats; Rats, Wistar; Rifampin

2008